Table 3 Pseudomonas aeruginosa serotype distribution by each investigator site
From: Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Investigator site | O1 | O2 | O6 | O10 | O11 | PL5 | NT | Total | |
|---|---|---|---|---|---|---|---|---|---|
1 | n | 2 | 0 | 8 | 2 | 1 | 2 | 1 | 16 |
% | 12.5% | 0.0% | 50.0% | 12.5% | 6.3% | 12.5% | 6.3% | 100% | |
2 | n | 1 | 0 | 3 | 2 | 2 | 3 | 2 | 13 |
% | 7.7% | 0.0% | 23.1% | 15.4% | 15.4% | 23.1% | 15.4% | 100% | |
3 | n | 2 | 4 | 12 | 1 | 14 | 4 | 3 | 40 |
% | 5.0% | 10.0% | 30.0% | 2.5% | 35.0% | 10.0% | 7.5% | 100% | |
4 | n | 0 | 0 | 3 | 1 | 3 | 1 | 2 | 10 |
% | 0.0% | 0.0% | 30.0% | 10.0% | 30.0% | 10.0% | 20.0% | 100% | |
5 | n | 1 | 1 | 5 | 0 | 1 | 2 | 0 | 10 |
% | 10.0% | 10.0% | 50.0% | 0.0% | 10.0% | 20.0% | 0.0% | 100% | |
6 | n | 4 | 5 | 4 | 1 | 2 | 2 | 0 | 18 |
% | 22.2% | 27.8% | 22.2% | 5.6% | 11.1% | 11.1% | 0.0% | 100% | |
7 | n | 0 | 1 | 1 | 5 | 1 | 2 | 2 | 12 |
% | 0.0% | 8.3% | 8.3% | 41.7% | 8.3% | 16.7% | 16.7% | 100% | |